Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment
GrannyFit
Digital Phenotyping (Physical Activity, Sleep) in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment
1 other identifier
interventional
200
1 country
4
Brief Summary
GrannyFit is a prospective, national, multicenter, single-arm open-label study. It will include a total of 200 participants over the age of 70 years treated for de novo or recurrent (local or distant) BC. Participants will receive a Withing Steel activity tracker, which they will be asked to wear 24 h per day for 12 months. The principal assessments will be performed at baseline, at 6 months and at 12 months. The investigators will evaluate clinical (e.g. comorbidities), lifestyle, quality of life, fatigue, and physical activity parameters. All questionnaires will be completed on a REDCap form, via a secure internet link.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Feb 2023
Typical duration for not_applicable breast-cancer
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2022
CompletedFirst Posted
Study publicly available on registry
December 2, 2022
CompletedStudy Start
First participant enrolled
February 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 19, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 19, 2026
August 27, 2025
July 1, 2025
3.3 years
November 22, 2022
August 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Describe physical activity profiles in breast cancer patients over 70 years of age
The activity tracker will register step counts for each day. the investigators will plot the average daily step counts and the 95% confidence interval across the entire study period. Then will will study the change in step count trajectory during the study. Linear mixed model will be used for describing change over time
Month 12
Describe sleep profiles in breast cancer patients over 70 years of age
The activity tracker will register sleep duration for each day. The investigators will plot the average sleep duration and the 95% confidence interval across the entire study period. Then will tudy the change in sleep duration trajectory during the study. Linear mixed model will be used for describing change over time
Month 12
Identify digital profiles (physical activity, sleep) in breast cancer patients over 70 years of age
To identify digital profiles, the investigators will combine step counts profiles and sleep profiles using mixed models with latent classes. The use of a mixed model will make it possible to analyze repeat data for the population, and to determine an average profile or trajectory for the whole population. The optimal number of classes will be determined a posteriori, based on a set of statistical and clinical criteria. The most widely used statistical criterion is the "Bayesian information criterion" (BIC), which penalizes the model's likelihood according to its complexity. The BIC, which is stricter than many other criteria, has been shown to have a better performance in simulations. The number of trajectories will also be based on clinical interpretation (whether it is worthwhile retaining classes containing very small numbers of subjects, etc.).
Month 12
Secondary Outcomes (7)
Analyze the effects of digital profiles on quality of life
Month 6, Month 12
Analyze the effects of digital profiles on fatigue
Month 6, Month 12
Analyze the effects of digital profiles on comorbidities
Month 6, Month 12
Analyze the effects of digital profiles on significant life events
Month 6, Month 12
Analyze the effects of digital profiles on physical activity
Month 6, Month 12
- +2 more secondary outcomes
Study Arms (1)
Intervention with activity tracker
EXPERIMENTALWomen allocated to the intervention arm will used an activity tracker
Interventions
Participants will receive a Withings Steel activity tracker (Withings, Issy-les-Moulineaux, France), which they will be asked to wear 24 hours per day throughout the whole intervention (12 months). At baseline, the Withings Health Mate mobile phone application will be downloaded onto each participant's smartphone or tablet. The clinical research assistant will instruct the participant in the use of the activity tracker. The participant will then accept and activate the sharing of the data collected with the secure server dedicated to the "GrannyFit" study at the Institut Curie. Participants will be asked to synchronize the activity tracker regularly (ideally daily) via Bluetooth with the Withings Health Mate application, for automatic transfer of the data to the secure "GrannyFit" space.
Eligibility Criteria
You may qualify if:
- Women over 70 years of age,
- With histologically confirmed invasive breast cancer,
- Regardless of histological subtype (hormone receptor positive (HR+), negative (HR-), with or without HER2 overexpression, or triple negative)
- PS ≤ 2,
- Willing and available to invest in the project for the duration of the study,
- Using a personal smartphone or personal tablet compatible with the "Withings Health Mate" app (iOS 10/android 5.0 and later) and with an internet connection,
- Affiliated with a social security plan,
- Having dated and signed an informed consent,
- Able to read, write and understand French.
You may not qualify if:
- Presence of disabling metastases,
- Moderate to severe cognitive impairment,
- Persons deprived of liberty or under guardianship,
- Inability to undergo the medical follow-up of the trial for geographical, social or psychological reasons,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Curielead
Study Sites (4)
Centre Léon Bérard
Lyon, 69008, France
Institut Curie
Paris, 75005, France
Institut GODINOT
Reims, 51100, France
Institut Curie
Saint-Cloud, 92210, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fabien Reyal, MD
Institut Curie
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2022
First Posted
December 2, 2022
Study Start
February 17, 2023
Primary Completion (Estimated)
May 19, 2026
Study Completion (Estimated)
May 19, 2026
Last Updated
August 27, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data requests can be submitted starting 9 months after last article publication and will be made accessible for up to 12 months.
- Access Criteria
- Access to trial individual participant data can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a data sharing agreement (DSA).
Sponsor will share de-identified data sets. Documents generated under the project will be disseminated in accordance with Institut Curie policies.